TRIODOS BANK NV (TRIO.AS) Fundamental Analysis & Valuation

AMS:TRIO • NL0010407946

Current stock price

29.08 EUR
-0.13 (-0.45%)
Last:

This TRIO.AS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. TRIO.AS Profitability Analysis

1.1 Basic Checks

  • In the past year TRIO has reported negative net income.
  • In the past year TRIO has reported a negative cash flow from operations.
  • Of the past 5 years TRIO 4 years were profitable.
  • In multiple years TRIO reported negative operating cash flow during the last 5 years.
TRIO.AS Yearly Net Income VS EBIT VS OCF VS FCFTRIO.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 500M -500M 1B -1B -1.5B

1.2 Ratios

  • With a Return On Assets value of -0.13%, TRIO is not doing good in the industry: 97.35% of the companies in the same industry are doing better.
  • TRIO has a worse Return On Equity (-1.78%) than 97.35% of its industry peers.
Industry RankSector Rank
ROA -0.13%
ROE -1.78%
ROIC N/A
ROA(3y)0.26%
ROA(5y)0.26%
ROE(3y)3.24%
ROE(5y)3.2%
ROIC(3y)N/A
ROIC(5y)N/A
TRIO.AS Yearly ROA, ROE, ROICTRIO.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 2 4

1.3 Margins

  • TRIO does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
TRIO.AS Yearly Profit, Operating, Gross MarginsTRIO.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 5 10 15

1

2. TRIO.AS Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for TRIO remains at a similar level compared to 1 year ago.
  • TRIO has more shares outstanding than it did 5 years ago.
  • TRIO has a worse debt/assets ratio than last year.
TRIO.AS Yearly Shares OutstandingTRIO.AS Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 5M 10M
TRIO.AS Yearly Total Debt VS Total AssetsTRIO.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

  • TRIO has a Debt/Equity ratio of 0.50. This is a neutral value indicating TRIO is somewhat dependend on debt financing.
  • TRIO has a Debt to Equity ratio of 0.50. This is amongst the best in the industry. TRIO outperforms 80.53% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACCN/A
TRIO.AS Yearly LT Debt VS Equity VS FCFTRIO.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 500M -500M 1B -1B -1.5B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
TRIO.AS Yearly Current Assets VS Current LiabilitesTRIO.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

3

3. TRIO.AS Growth Analysis

3.1 Past

  • The earnings per share for TRIO have decreased strongly by -128.31% in the last year.
  • TRIO shows a decrease in Revenue. In the last year, the revenue decreased by -4.82%.
  • TRIO shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.82% yearly.
EPS 1Y (TTM)-128.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-52.94%
Revenue 1Y (TTM)-4.82%
Revenue growth 3Y10.67%
Revenue growth 5Y9.82%
Sales Q2Q%-6.59%

3.2 Future

  • The Earnings Per Share is expected to grow by 127.12% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, TRIO will show a decrease in Revenue. The Revenue will decrease by -0.10% on average per year.
EPS Next Y198.76%
EPS Next 2Y378.73%
EPS Next 3Y195.06%
EPS Next 5Y127.12%
Revenue Next Year-5.79%
Revenue Next 2Y-1.79%
Revenue Next 3Y-0.05%
Revenue Next 5Y-0.1%

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
TRIO.AS Yearly Revenue VS EstimatesTRIO.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M
TRIO.AS Yearly EPS VS EstimatesTRIO.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 2028 1 2 3 4 5

4

4. TRIO.AS Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for TRIO. In the last year negative earnings were reported.
  • Based on the Price/Forward Earnings ratio of 6.62, the valuation of TRIO can be described as very cheap.
  • Based on the Price/Forward Earnings ratio, TRIO is valued cheaper than 97.35% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 23.80, TRIO is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 6.62
TRIO.AS Price Earnings VS Forward Price EarningsTRIO.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
TRIO.AS Per share dataTRIO.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as TRIO's earnings are expected to grow with 195.06% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y378.73%
EPS Next 3Y195.06%

0

5. TRIO.AS Dividend Analysis

5.1 Amount

  • TRIO does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

TRIO.AS Fundamentals: All Metrics, Ratios and Statistics

TRIODOS BANK NV

AMS:TRIO (3/18/2026, 7:00:00 PM)

29.08

-0.13 (-0.45%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners5.37%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap0
Revenue(TTM)462.91M
Net Income(TTM)-22.15M
Analysts80
Price Target37.06 (27.44%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-8.02%
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-80.91%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-3.05%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 6.62
P/S 0.89
P/FCF N/A
P/OCF N/A
P/B 0.33
P/tB 0.35
EV/EBITDA N/A
EPS(TTM)-1.56
EYN/A
EPS(NY)4.39
Fwd EY15.11%
FCF(TTM)-18.17
FCFYN/A
OCF(TTM)-16.9
OCFYN/A
SpS32.61
BVpS87.44
TBVpS84.21
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -0.13%
ROE -1.78%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)0.26%
ROA(5y)0.26%
ROE(3y)3.24%
ROE(5y)3.2%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 69.53%
Cap/Sales 3.9%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score1
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)71.82%
Cap/Depr(5y)72.44%
Cap/Sales(3y)4.33%
Cap/Sales(5y)4.69%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-128.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-52.94%
EPS Next Y198.76%
EPS Next 2Y378.73%
EPS Next 3Y195.06%
EPS Next 5Y127.12%
Revenue 1Y (TTM)-4.82%
Revenue growth 3Y10.67%
Revenue growth 5Y9.82%
Sales Q2Q%-6.59%
Revenue Next Year-5.79%
Revenue Next 2Y-1.79%
Revenue Next 3Y-0.05%
Revenue Next 5Y-0.1%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-8.16%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-8.9%
OCF growth 3YN/A
OCF growth 5YN/A

TRIODOS BANK NV / TRIO.AS Fundamental Analysis FAQ

What is the fundamental rating for TRIO stock?

ChartMill assigns a fundamental rating of 2 / 10 to TRIO.AS.


Can you provide the valuation status for TRIODOS BANK NV?

ChartMill assigns a valuation rating of 4 / 10 to TRIODOS BANK NV (TRIO.AS). This can be considered as Fairly Valued.


Can you provide the profitability details for TRIODOS BANK NV?

TRIODOS BANK NV (TRIO.AS) has a profitability rating of 1 / 10.


How financially healthy is TRIODOS BANK NV?

The financial health rating of TRIODOS BANK NV (TRIO.AS) is 1 / 10.